Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

Q+A: AMGA says MACRA proposed rule sends wrong message on value-based care

Groups representing physicians, hospitals, internists and health IT were quick to praise the proposed rule for the second year of the new payment tracks under the Medicare Access and CHIP Reauthorization Act (MACRA). The American Medical Group Association, however, has a decidedly different take.

The push toward utilizing IoT

The “internet of things” (IoT) is the bright future of connected technology, yet remains underutilized by healthcare organizations. In a preview presentation by Paul Perry, director of Warren Averett security services, IoT is highlighted for is benefits with connected health.

Iredell Memorial Hospital utilizes UV light to eliminate pathogens

In an effort to keep hospital rooms safe from drug-resistant organism for providers, patients and their families, Iredell Health System has implemented ultraviolet (UV) technology to better detect those pathogens.

Thumbnail

Senate’s version of ACA repeal released

The legislation takes many provisions from the House-passed American Health Care Act (AHCA) under a new name: the Better Care Reconciliation Act (BCRA).

Upstep launches one stop custom orthotics online service in the U.S.

Upstep (https://www.upstep.com), founded by Israeli entrepreneurs, is launching a comprehensive online service to buy custom made orthotics designed by world-class podiatrists. Prices represent 35%-50% savings over the direct purchase from podiatrists.

Portable smartphone sensor identifies disease outbreaks, pollution

Testing for carcinogens, pollution and contaminants involves an array of large and expensive sensors accompanied by a trained professional. Researchers have introduced, in ACS Sensors, a new detection system utilizing portable, low-cost sensors paired with a smartphone application to fast track results with high accuracy.

Thumbnail

Proposed MACRA changes praised in initial industry reaction

The American Medical Association (AMA) and the American Hospital Association (AHA) appear pleased with the proposed rule for the second year of the Quality Payment Program (QPP), with some groups reserving judgment until they have time to review the 1,058-page regulation.

Thumbnail

CMS proposes raising low-volume exemption, adding virtual groups in MACRA’s second year

The proposed rule for the second year of the Medicare Access and CHIP Reauthorization Act’s (MACRA) Quality Payment Program (QPP) has been released by CMS, with its stated goal to “simplify the program, especially for small, independent, and rural practices, while ensuring fiscal sustainability and high-quality care.”

Displaying 4513 - 4520 of 6648

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup